Repositorio Dspace

Listar por autor "Muñoz-Esparza, Carmen"

Listar por autor "Muñoz-Esparza, Carmen"

Ordenar por:Orden:Resultados:

  • A Primary Prevention Clinical Risk Score Model for Patients With Brugada Syndrome (BRUGADA-RISK) 
    Honarbakhsh, Shohreh; Providencia, Rui; García-Hernández, Jorge; Martin, Claire-A; Hunter, Ross-J; Lim, Wei-Y; Kirkby, Claire; Graham, Adam-J; Sharifzadehgan, Ardalan; Waldmann, Víctor; Marijon, Eloi; Muñoz-Esparza, Carmen; Lacunza, Javier; Gimeno-Blanes, Juan-Ramón; Ankou, Benedicte; Chevalier, Philippe; Antonio, Natalia; Elvas, Luis; Castelletti, Silvia; Crotti, Lia; Schwartz, Peter; Scanavacca, Mauricio; Darrieux, Francisco; Sacilotto, Lucíana; Mueller-Leisse, Johanna; Veltmann, Christian; Vicentini, Alessandro; Demarchi, Andrea; Cortez-Dias, Nuno; Antonio, Pedro-Silverio; de-Sousa, Joao; Adragao, Pedro; Cavaco, Diogo; Costa, Francisco-Morosco; Khoueiry, Ziad; Boveda, Serge; Sousa, Mario-Joao; Jebberi, Zeynab; Heck, Patrick; Mehta, Sarju; Conte, Giulio; Ozkartal, Tardu; Auricchio, Ángelo; Lowe, Martín-D; Schilling, Richard-J; Prieto-Merino, David; Lambiase, Pier-D (ELSEVIER, 2021-02)
    OBJECTIVES: The goal of this study was to develop a risk score model for patients with Brugada syndrome (BrS). BACKGROUND: Risk stratification in BrS is a significant challenge due to the low event rates and conflicting ...
  • Electrocardiogram May Fail to Identify Proportion of High-Risk Individuals: Analysis of Series of 50 Sudden Death Cases 
    Salar-Alcaraz, María-Eladia; Peñafiel-Verdú, Pablo; Castro-García, Francisco-J; Pastor-Quirante, Francisco-Antonio; Muñoz-Esparza, Carmen; López-Ayala, José-M; Martínez-Sánchez, Juan; Sánchez-Muñoz, Juan-José; García-Alberola, Arcadio; Sabater-Molina, María; Gimeno-Blanes, Juan-Ramón (MDPI, 2025-02-10)
  • Genetic Factors Involved in Cardiomyopathies and in Cancer 
    Sabater-Molina, María; Navarro-Peñalver, Marina; Muñoz-Esparza, Carmen; Esteban-Gil, Ángel; Santos-Mateo, Juan-José; Gimeno-Blanes, Juan-Ramón (MDPI, 2020-06)
    Cancer therapy-induced cardiomyopathy (CCM) manifests as left ventricular (LV) dysfunction and heart failure (HF). It is associated withparticular pharmacological agents and it is typically dose dependent, but significant ...
  • Impact of physical activity on presentation and prognosis of Brugada syndrome 
    Fernández-Gil, María-Jesús; Carrillo-Mora, Lidia-María; Fernández-Vázquez, David; Melgarejo-Meseguer, Francisco-Manuel; Santos-Mateo, Juan-José; Muñoz-Esparza, Carmen; Rodríguez-Serrano, Ana-Isabel; Navarro-Peñalver, Marina; Sánchez-Muñoz, Juan-José; Gimeno-Blanes, Juan-Ramón; Sabater-Molina, María; Gimeno-Blanes, Juan-Ramón (BMJ PUBLISHING GROUP, 2025-07)
    INTRODUCTION AND OBJECTIVES: Brugada syndrome (BS) is a channelopathy associated with an increased risk of sudden cardiac death (SCD). Intense physical activity is a recognised trigger of life-threatening arrhythmias in ...
  • Medium- and long-term outcome after a single second-generation cryoballoon ablation in patients with paroxysmal and persistent atrial fibrillation 
    Elvira-Ruiz, Ginés; Peñafiel-Verdu, Pablo; Martínez-Sánchez, Juan-Carlos; Sánchez-Muñoz, Juan-José; García-Almagro, Francisco-José; Muñoz-Esparza, Carmen; García-Alberola, Arcadio (ELSEVIER ESPANA SLU, 2019-12)
  • Prevented Sudden Cardiac Death and Neurologic Recovery in Inherited Heart Diseases 
    Hernández-del-Rincón, Juan-P; Olmo-Conesa, Mari-C; Rodríguez-Serrano, Ana; García-Pulgar, Helena; López-Cuenca, David; Muñoz-Esparza, Carmen; Navarro-Peñalver, Marina; Santos-Mateo, Juan-José; Nicolás-Rocamora, Elisa; Gil-Ortuño, Cristina; Sabater-Molina, María; Gimeno-Blanes, Juan-Ramón; Pastor-Quirante, Francisco (FRONTIERS MEDIA SA, 2021-03)
    Introduction: Inherited cardiovascular diseases are an important cause of sudden cardiac death (SD). The use of risk scores identify high risk patients who would benefit from an implantable cardioverter-defibrillators ...
  • Trabeculated Myocardium in Hypertrophic Cardiomyopathy: Clinical Consequences 
    David-Casanova, José; González-Carrillo, Josefa; Martín-Jiménez, Jesús; Cuenca-Muñoz, Javier; Muñoz-Esparza, Carmen; Siguero-Álvarez, Marcos; Escriba, Rubén; Burillo-Milla, Esther; de-la-Pompa, José-Luis; Raya, Ángel; Gimeno-Blanes, Juan-Ramón; Sabater-Molina, María; Bernabé-García, Gregorio (MDPI, 2020-10)
    AIMS: Hypertrophic cardiomyopathy (HCM) is often accompanied by increased trabeculated myocardium (TM)-which clinical relevance is unknown. We aim to measure the left ventricular (LV) mass and proportion of trabeculation ...